Iovance Biotherapeutics IOVA Stock
Iovance Biotherapeutics Price Chart
Iovance Biotherapeutics IOVA Financial and Trading Overview
| Iovance Biotherapeutics stock price | 3.23 USD |
| Previous Close | 8.67 USD |
| Open | 8.59 USD |
| Bid | 0 USD x 1000 |
| Ask | 0 USD x 4000 |
| Day's Range | 8.52 - 8.82 USD |
| 52 Week Range | 5.28 - 13.44 USD |
| Volume | 6M USD |
| Avg. Volume | 5.07M USD |
| Market Cap | 1.94B USD |
| Beta (5Y Monthly) | 0.180633 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.28 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 22.38 USD |
IOVA Valuation Measures
| Enterprise Value | 1.44B USD |
| Trailing P/E | N/A |
| Forward P/E | -5.647059 |
| PEG Ratio (5 yr expected) | 0.2 |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 2.9071336 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -3.534 |
Trading Information
Iovance Biotherapeutics Stock Price History
| Beta (5Y Monthly) | 0.180633 |
| 52-Week Change | -1.36% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 13.44 USD |
| 52 Week Low | 5.28 USD |
| 50-Day Moving Average | 7.08 USD |
| 200-Day Moving Average | 7.64 USD |
IOVA Share Statistics
| Avg. Volume (3 month) | 5.07M USD |
| Avg. Daily Volume (10-Days) | 5.69M USD |
| Shares Outstanding | 224.45M |
| Float | 178.24M |
| Short Ratio | 3.17 |
| % Held by Insiders | 0.36% |
| % Held by Institutions | 89.98% |
| Shares Short | 21.65M |
| Short % of Float | 10.62% |
| Short % of Shares Outstanding | 9.64% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:100 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -34.24% |
| Return on Equity (ttm) | -67.54% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -407744000 USD |
| Net Income Avi to Common (ttm) | -411656000 USD |
| Diluted EPS (ttm) | -2.7 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 626.29M USD |
| Total Cash Per Share (mrq) | 2.79 USD |
| Total Debt (mrq) | 83.23M USD |
| Total Debt/Equity (mrq) | 12.48 USD |
| Current Ratio (mrq) | 7.308 |
| Book Value Per Share (mrq) | 2.972 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -318769984 USD |
| Levered Free Cash Flow (ttm) | -175051120 USD |
Profile of Iovance Biotherapeutics
| Country | United States |
| State | CA |
| City | San Carlos |
| Address | 825 Industrial Road |
| ZIP | 94070 |
| Phone | 650 260 7120 |
| Website | https://www.iovance.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 503 |
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. The company's lead product candidate is lifileucel that is in Phase II clinical trial for the treatment of metastatic melanoma and cervical cancer. It also develops LN-145 for the treatment of metastatic non-small cell lung cancer; IOV-4001 for the treatment of melanoma non-small cell lung cancer; IOV-2001; and IOV-3001. Iovance Biotherapeutics, Inc. has collaborations and licensing agreements with H. Lee Moffitt Cancer Center; M.D. Anderson Cancer Center; Ohio State University; Centre hospitalier de l'Université de Montreal; Cellectis S.A.; Novartis Pharma AG; Melanoma Institute Australia; and Beth-Israel Deaconess Medical Center. The company was formerly known as Lion Biotechnologies, Inc. and changed its name to Iovance Biotherapeutics, Inc. in June 2017. Iovance Biotherapeutics, Inc. was incorporated in 2007 and is headquartered in San Carlos, California.
Q&A For Iovance Biotherapeutics Stock
What is a current IOVA stock price?
Iovance Biotherapeutics IOVA stock price today per share is 3.23 USD.
How to purchase Iovance Biotherapeutics stock?
You can buy IOVA shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Iovance Biotherapeutics?
The stock symbol or ticker of Iovance Biotherapeutics is IOVA.
Which industry does the Iovance Biotherapeutics company belong to?
The Iovance Biotherapeutics industry is Biotechnology.
How many shares does Iovance Biotherapeutics have in circulation?
The max supply of Iovance Biotherapeutics shares is 327.88M.
What is Iovance Biotherapeutics Price to Earnings Ratio (PE Ratio)?
Iovance Biotherapeutics PE Ratio is now.
What was Iovance Biotherapeutics earnings per share over the trailing 12 months (TTM)?
Iovance Biotherapeutics EPS is -1.28 USD over the trailing 12 months.
Which sector does the Iovance Biotherapeutics company belong to?
The Iovance Biotherapeutics sector is Healthcare.
Iovance Biotherapeutics IOVA included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16823.17 USD — |
-0.05
|
6.87B USD — | 16753.22 USD — | 16979.96 USD — | — - | 6.87B USD — |
| NASDAQ Biotechnology NBI | 4010.46 USD — |
-0.39
|
— — | 3978.56 USD — | 4047.74 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 898.33 USD — |
-0.3
|
— — | 891.62 USD — | 905.39 USD — | — - | — — |
| Nasdaq US 700 Small Cap Index NQUS700SC | 1984.88 USD — |
-0.07
|
— — | 1976.77 USD — | 2006.81 USD — | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 4153.28 USD — |
+1.21
|
— — | 4281.91 USD — | 4648.11 USD — | — - | — — |
| NASDAQ Global Market Composite NQGM | 1758.63 USD — |
+0.01
|
— — | 1740.1 USD — | 1772.91 USD — | — - | — — |
- {{ link.label }} {{link}}